My friends over at Mesomorphosis.com have recently published some very interesting bodybuilding and anabolic steroid articles that I wanted to share with you. In the article, Dopers no uniforme: Policiais em esteróides, John Hoberman looks at how cops can apparently use tons of steroids with almost complete impunity while at the same time, Congress cracks down on steroids in sports.

Also at Mesomorphosis.com, they have a new article from my friend Rick Collins titled - Ephedra: Interpreting the New Court Ruling, in this article, Rick looks at the current legal state of Ephedra - sim, it\'s legal again... sort of. You\'ll definitely want to read this article. Abaixo, there are the excerpts and also the links to the full story. Apreciar!

Dopers no uniforme: Policiais em esteróides - by John Hoberman, PhD

As the U.S. Congress continues its assault on AAS use among professional athletes, longtime observers of doping control initiatives will recognize the selective indignation that continues to sensationalize the use of these drugs by athletes. The fact that certain groups of AAS consumers have been spared the special opprobrium reserved for sports heroes who fail to serve as proper "role models" for youth demonstrates once again how arbitrary and politically motivated the formulation and enforcement of drug laws can be. One of the remarkable anomalies of the anti-AAS campaign of the past two decades is that it has virtually ignored the many reports of AAS use by police officers in the United States and in other countries. Leia mais....

Maio 8, 2005- Ephedra: Interpreting the New Court Ruling by Rick Collins - Recentemente, a federal court in Salt Lake City [U.S. District Court for the District of Utah, Central Division] issued its decision on a legal challenge to FDA’s 2004 Final Rule banning all ephedrine-alkaloid dietary supplements. Judge Tena Campbell’s decision made two key points: (1) It held that the analysis used by FDA was incorrect and improper. The court held that requiring supplement companies to demonstrate a benefit as a pre-condition to marketing violated DSHEA by shifting the burden from FDA to industry. (2) It held that FDA didn’t have adequate scientific evidence to find that a daily dose of 10 mg. or less of ephedrine alkaloids presented a "significant or unreasonable risk of illness or injury." The court effectively held that it’s improper to ban all ephedra supplements because FDA lacks data to determine what dosage might be safe.

Maio 1, 2005 - Rick Collins\' Testimony to the United States Sentencing Commission

Abril 24, 2005 - Just Say "Yes" to AAS by Sidney Gendin, PhD

Abril 17, 2005 - Radio Silence: The Media\'s Response to AAS Testing by Will Carroll

Março 27, 2005 - AAS, Sluggers and the War on Drugs by John Hoberman, PhD

Março 20, 2005 -Congressional Hearings on "AAS in Baseball" - Hearings Without Listening by Will Carroll

[Sc:aprovação-std]